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Summary
Cholesterol and fatty acid synthesis in mammals are
controlled by SREBPs, a family of membrane bound
transcription factors. Our studies identified homologs
of SREBP, its binding partner SCAP, and the ER reten-
tion protein Insig in Schizosaccharomyces pombe,
named sre1+, scp1+, and ins1+. Like SREBP, Sre1 is
cleaved and activated in response to sterol depletion
in a Scp1-dependent manner. Microarray analysis re-
vealed that Sre1 activates sterol biosynthetic en-
zymes as in mammals, and, surprisingly, Sre1 also
stimulates transcription of genes required for adapta-
tion to hypoxia. Furthermore, Sre1 rapidly activates
these target genes in response to low oxygen and is
itself required for anaerobic growth. Based on these
findings, we propose and test a model in which Sre1
and Scp1 monitor oxygen-dependent sterol synthesis
as an indirect measure of oxygen supply and mediate
a hypoxic response in fission yeast.
Introduction
Lipid homeostasis in mammalian cells is controlled by
a family of ER membrane bound transcription factors
called sterol regulatory element binding proteins (SREBPs)
(Rawson, 2003). Two genes code for three SREBP iso-
forms, named SREBP-1a, SREBP-1c, and SREBP-2. To
date, SREBPs are known to activate transcription of
more than 30 genes needed for uptake and synthesis
of cholesterol, fatty acids, triglycerides, and phospho-
lipids (Horton et al., 2002). Activity of SREBPs is regu-
lated by sterol feedback inhibition, with SREBP being
active in sterol-depleted cells and inactive when cho-
lesterol accumulates.
SREBPs contain two transmembrane segments and
are inserted into ER membranes in a hairpin fashion
such that the N- and C-terminal ends of the protein pro-
ject into the cytosol (Figure 1A). The SREBP N terminus
is a transcription factor of the basic helix-loop-helix-
leucine zipper (bHLH-zip) family, and the C terminus
binds to the C terminus of SREBP cleavage activating
protein, SCAP (Rawson, 2003). SCAP is an ER mem-
brane protein that contains eight transmembrane seg-
ments and is a component of the sterol sensor (Figure
1B). Cells containing mutations in the sterol-sensing
domain (SSD, transmembrane segments 2–6) of SCAP
fail to sense sterols, resulting in activation of SREBP
even in the presence of high sterol levels (Yabe et al.,
2002).*Correspondence: peter.espenshade@jhmi.eduSREBP is activated by two sequential proteolytic
cleavage events in the Golgi (Rawson, 2003). Sterols
control activation of SREBP by regulating access of
SREBP to the Golgi-localized Site-1 and Site-2 prote-
ases. In sterol-replete cells, SCAP forms a complex
with the ER resident protein Insig (Yang et al., 2002). As
a result, ER exit of SREBP-SCAP complex is blocked,
preventing activation of SREBP. In sterol-depleted
cells, SCAP escorts SREBP from the ER to the Golgi
where the Site-1 and Site-2 proteases cleave SREBP
and release the N-terminal transcription factor (De-
Bose-Boyd et al., 1999). How SCAP and Insig function
to sense sterols is unknown.
To date, SREBP homologs have been characterized
in two model genetic organisms, D. melanogaster and
C. elegans. Both organisms are sterol auxotrophs and
thus do not regulate sterol synthesis (McKay et al.,
2003; Seegmiller et al., 2002). Consequently, SREBP
only regulates genes required for fatty acid synthesis in
these organisms. Furthermore, while Drosophila SREBP
is activated by an orthologous SCAP-dependent mech-
anism, cleavage of dSREBP is regulated by levels of
phosphatidylethanolamine, not sterols (Dobrosotskaya
et al., 2002). In contrast, yeast synthesize ergosterol, a
sterol structurally similar to cholesterol. We therefore
postulated that yeast may possess an SREBP pathway
to regulate ergosterol homeostasis.
In this study, we present the characterization of an
SREBP pathway in a unicellular eukaryote, the fission
yeast S. pombe. We demonstrate that sre1+ and scp1+
are functional orthologs of SREBP and SCAP and that
yeast activate Sre1 in response to sterol depletion. Sur-
prisingly, sre1+ is essential only for anaerobic growth,
and sre1+ regulates genes required for adaptation to
hypoxia. Our data support a model whereby in low oxy-
gen, the Sre1-Scp1 complex senses a decrease in oxy-
gen-dependent sterol synthesis, leading to proteolytic
activation of Sre1 and transcriptional adaptation to
hypoxia. We therefore propose that Sre1-Scp1 function
as an oxygen sensor in fission yeast.
Results
SREBP Pathway in Fission Yeast
Sequence searches failed to identify a SREBP homolog
in S. cerevisiae, but two genes homologous to human
SREBP-1a, sre1+ and sre2+, were identified in the fis-
sion yeast S. pombe (Figure 1A). Despite low overall
sequence identity to SREBP-1a, the N-terminal do-
mains of Sre1 and Sre2 contain basic bHLH-zip DNA
binding domains with high identity to the SREBP-1a
bHLH domain, 59% and 63% for Sre1 and Sre2, respec-
tively. Importantly, Sre1 and Sre2 contain a unique tyro-
sine residue in the bHLH domain that distinguishes
SREBPs from other bHLH transcription factors (Parraga
et al., 1998). Like mammalian SREBPs, the N termini of
Sre1 and Sre2 are serine- and proline-rich, with these
amino acids comprising 32% and 27%, respectively, of
residues preceding the bHLH domain (Hua et al., 1993).
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832Figure 1. S. pombe Homologs of Mammalian SREBP, SCAP, and Insig
Transmembrane helix prediction plots of human SREBP-1a (A), hamster SCAP (B), and human Insig-1 (C) calculated using TMHMM software
(version 2.0) are shown in comparison to their S. pombe homologs. Protein lengths are given in amino acids (aa). Heavy bars indicate regions
of high sequence identity. For SREBP, the amino acid position of the highly conserved tyrosine in the bHLH zipper domain (bHLH-zip) is
given. For SCAP, the positions of three conserved residues in the sterol-sensing domain (SSD) that confer constitutive activity on SCAP are
shown (Yabe et al., 2002). Predicted membrane topology is diagrammed (not to scale) for each protein. ORF designations are as follows:
sre1+, SPBC19C2.09; sre2+, SPBC354.05c; scp1+, SPBC3B9.15c; and ins1+, SPCC306.05c. (D) Wild-type or scp1-Myc yeast (3 × 107 cells)
were harvested, and detergent-solubilized extracts were prepared as described in Experimental Procedures. Proteins associated with Scp1-
Myc were immunopurified using anti-Myc IgG-9E10 monoclonal antibody. Equal fractions of bound (lanes 1 and 2) and unbound (lanes 3 and
4) protein were subjected to immunoblot analysis using anti-Sre1(aa 1–260) IgG, anti-Sre2 (aa 1–426) serum, or anti-Myc IgG-Poly as indicated.Sre1 and Sre2 are predicted to contain two transmem- S
Sbrane helices, suggesting that these proteins are mem-
brane bound transcription factors with a topology sim-
Silar to mammalian SREBP. Interestingly, while Sre1 andre2 share overall topology, Sre2 lacks the C-terminal
CAP-interacting domain found in mammalian SREBPs.
Fission yeast also contains a single homolog of
CAP that we named scp1+ (Figure 1B). Both mamma-
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tain eight transmembrane helices and a large C-ter-
minal domain with multiple WD repeats (Smith et al.,
1999). Membrane helices 2–6 of SCAP comprise the
sterol-sensing domain (SSD) that controls activation of
SREBP in response to sterol levels. Previous studies
identified three amino acids in the SSD of SCAP re-
quired for binding to Insig and retention in the ER:
Tyr298, Leu315, and Asp443 (Yabe et al., 2002). Muta-
tion of these residues causes the SREBP-SCAP com-
plex to exit the ER constitutively, regardless of sterol
concentration. Importantly, despite the fact that SCAP
and Scp1 share little overall sequence identity, patches
of identity surround these three conserved residues in
the Scp1 SSD (Tyr247, Leu264, Asp392), suggesting
that Scp1 may sense sterols in yeast.
Lastly, database searches revealed a sequence ho-
molog of human Insig-1 that we named ins1+ (Figure
1C) (Loewen and Levine, 2002). Overall sequence iden-
tity between the two proteins is low (21%), but the pro-
teins are nearly identical in length and predicted topol-
ogy. Based on a recent characterization of Insig-1, Ins1
also likely contains six transmembrane segments (Fera-
misco et al., 2004).
To test whether Scp1 and Sre1 form a complex, we
constructed scp1-Myc, a yeast strain that expresses
Scp1 with a C-terminal 13xMyc tag from the endoge-
nous scp1+ promoter. We purified Scp1 complexes
from wild-type and scp1-Myc detergent cell extracts
using anti-Myc antibody, and equal amounts of bound
and unbound fractions were analyzed. Immunoblotting
with antibody to the N terminus of Sre1 shows that
greater than 50% of endogenous Sre1 is bound to
Scp1-Myc (Figure 1D, upper panel, lanes 2 and 4). No
Sre1 was recovered from wild-type cells that lack the
Myc epitope (Figure 1D, lane 1). To test the specificity
of Scp1-Sre1 binding, we probed the same samples
with antibody to the N terminus of the closely related
Sre2. Scp1-Myc failed to bind to Sre2 (Figure 1D, mid-
dle panel, lane 2), likely due to the absence of a Scp1-
interacting domain in Sre2. These data demonstrate
that Scp1 and Sre1 form a complex in fission yeast.
To investigate whether Sre1 is cleaved in response to
sterol depletion in fission yeast, wild-type cells were
cultured in the absence or presence of compactin, a
sterol synthesis inhibitor that blocks production of
mevalonate by HMG-CoA reductase (Brown et al.,
1978). Under these conditions, compactin treatment
completely blocked ergosterol synthesis (our unpub-
lished data). In untreated wild-type yeast, antibody to
the N terminus of Sre1 specifically detected the w110
kDa full-length Sre1 precursor and minor protein spe-
cies w70–80 kDa (Figure 2A, compare lanes 1 and 5).
Treatment of cells with compactin caused a slight re-
duction in the level of Sre1 precursor and the appear-
ance of cleaved N terminus of Sre1 (Sre1-N) that mi-
grated as a broad smear from w55–80 kDa (Figure 2A,
lane 3). Proteolysis of Sre1 in response to compactin
was specific insomuch as it was repressed when ergos-
terol synthesis was restored by addition of mevalonate,
the direct product of HMG-CoA reductase (Figure 2A,
lane 4). These data suggest that Sre1 is proteolytically
processed in sterol-depleted cells.
Cleavage and membrane release of Sre1 by a Site-2protease-like mechanism should produce a protein of
w50 kDa (amino acids 1–440). However, Sre1-N mi-
grated as a smear, suggesting that Sre1-N is modified
posttranslationally. The high content of serine and thre-
onine residues in the N terminus of Sre1 (72 of first 250
residues) indicated that Sre1-N may be phosphory-
lated. To examine this possibility, compactin-treated
protein extracts were incubated with alkaline phospha-
tase prior to immunoblotting. Phosphatase treatment
collapsed the Sre1-N smear to a single band (Figure
2B, lane 2). Addition of EGTA inhibits the phosphatase
and blocked this mobility change (Figure 2B, lane 3).
Phosphatase treatment of cells grown in the absence
of compactin revealed that untreated cells contain a
low level of Sre1 cleavage (Figure 2B, lane 5). Phospha-
tase treatment had no effect on the mobility of the Sre1
precursor, suggesting that phosphorylation occurs af-
ter proteolysis.
To investigate the requirements for Sre1 cleavage,
wild-type and mutant cells were grown in the absence
or presence of compactin, and whole-cell extracts were
immunoblotted for Sre1 before and after phosphatase
treatment. As in mammalian cells, Sre1 processing re-
quired Scp1, and deletion of scp1+ reduced the level of
Sre1 precursor (Figure 2C, lanes 1 and 2 and 5 and 6)
(Rawson et al., 1999). The inability to detect Sre1-N in
scp1D cells was not due to reduced levels of Sre1 pre-
cursor (Figure 2C, lanes 11 and 12). Interestingly, dele-
tion of ins1+ or sre2+ had no effect on Sre1 cleavage
(Figure 2C, lanes 7–10), indicating that Ins1 is not
essential for ER retention of Scp1 in fission yeast.
In addition to blocking sterol synthesis, compactin
inhibits formation of isoprenoids used to modify pre-
nylated proteins and to synthesize ubiquinone and
heme A (Goldstein and Brown, 1990). To confirm that
Sre1 cleavage resulted from reduced sterol synthesis,
we assayed Sre1 cleavage in the presence of two addi-
tional ergosterol synthesis inhibitors: zaragozic acid
and itraconazole. Importantly, both drugs block steps
downstream of isoprenoid synthesis. Zaragozic acid in-
hibits squalene synthase, and itraconazole blocks
demethylation of lanosterol, the first sterol in the ergos-
terol synthesis pathway. Treatment of wild-type yeast
with zaragozic acid or itraconazole induced cleavage
of Sre1 to levels seen with compactin treatment (Figure
2D, lanes 2–4), suggesting that Sre1 responded specifi-
cally to a decrease in sterol synthesis. Treatment with
DMSO, the vehicle for itraconazole, had no effect on
cleavage (Figure 2D, lane 5). Collectively, these data
suggest that fission yeast Sre1 is activated and cleaved
in response to sterol depletion by a Scp1-dependent
mechanism.
Transcriptional Regulation by Sre1
Mammalian SREBPs directly regulate transcription of
more than 30 genes required for cholesterol and fatty
acid synthesis (Horton et al., 2003). Deletion of SCAP
from mouse liver decreases transcription of HMG-CoA
reductase (five times), HMG-CoA synthase (nine times),
and fatty acid synthase (11 times) (Matsuda et al.,
2001). To investigate whether Sre1 regulates the homol-
ogous S. pombe genes, we grew wild-type and mutant
yeast in the absence or presence of compactin and ex-
Cell
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(A) Wild-type and sre1D yeast were cultured in the absence or presence of 200 M compactin and 50 mM mevalonate for 6 hr as indicated.
Whole-cell extracts were subjected to immunoblot analysis using anti-Sre1 IgG. P and N denote the precursor and cleaved nuclear forms of
Sre1, respectively. Molecular mass standards (kD) are shown.
(B) Wild-type yeast were cultured in the presence (lanes 1–3) or absence (lanes 4–6) of 200 M compactin for 6 hr. Cell extracts (10 g of
protein) were treated with alkaline phosphatase and 25 mM EGTA for 1 hr at 37°C as indicated. Treated samples were subjected to immunoblot
analysis using anti-Sre1 IgG.
(C) Wild-type and mutant yeast were cultured in the absence or presence of 200 M compactin for 6 hr as indicated. Cell extracts were
subjected to immunoblot analysis using anti-Sre1 IgG before and after treatment with alkaline phosphatase (upper and lower panels, respec-
tively). Samples in lanes 11 and 12 contain four times the amount of protein as lanes 1–10. Asterisks indicate anti-Sre1 crossreacting proteins.
(D) Wild-type yeast were grown for 6 hr in the absence or presence of ergosterol synthesis inhibitors: C, 200 M compactin; Z, 10 M
zaragozic acid; I, 85 M itraconazole in 0.6% DMSO; and D, 0.6% DMSO. Cell extracts were subjected to immunoblot analysis using anti-
Sre1 IgG.amined target gene expression in response to Sre1 ac- S
wtivation. As shown previously, Sre1 was cleaved in re-
sponse to sterol depletion, and cleavage required Scp1 4
t(Figure 3, top panel). Surprisingly, expression of homo-
logs to human HMG-CoA reductase (hmg1+), HMG-CoA c
bsynthase (hcs1+), and fatty acid synthase (fas1+ and
lsd1+, the β and α subunits, respectively) was indepen- s
cdent of sterol levels and Sre1 activity, as mRNA levels
were unchanged under all conditions (Figure 3, bot- z
ytom panel).
To identify physiological targets of Sre1, we per- e
iformed microarray analysis using mRNA isolated from
wild-type and scp1D yeast grown in the presence of r
(compactin. This experiment allowed us to detect Sre1-
dependent transcription by comparing differences in s
Tgene expression between a strain with fully activatedre1 (Figure 3, top panel, wild-type, lane 2) and a strain
ith no Sre1 cleavage (Figure 3, top panel, scp1D, lane
). Table 1 lists the ten genes whose expression showed
he greatest difference between wild-type and scp1D
ells. As expected, scp1+ showed the largest change
ecause we were comparing wild-type and scp1D
trains. The genes most highly upregulated by Sre1 in-
luded the following: hem13+, a heme biosynthetic en-
yme; scs7+ and sur2+, two genes required for hydrox-
lation of sphingolipids; and, importantly, erg3+ and
rg25+, two genes that code for enzymes acting late
n the ergosterol synthesis pathway. In addition, Sre1
egulated its own expression as in mammalian cells
Horton et al., 2003). RNA expression data for hem13+,
re1+, and erg3+ are shown in Figure 3 (bottom panels).
ranscription of each gene increased in sterol-depleted
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Wild-type and mutant yeast were grown for 9 hr in the absence
(lane 1) or presence (lanes 2–4) of 50 M compactin. (Top panel)
Cell extracts were subjected to immunoblot analysis using anti-
Sre1 IgG. (Bottom panel) Total RNA was prepared from 2 × 109 cells
and used for Northern blotting and DNA microarray analysis (see
Table 1) as described in Experimental Procedures. Aliquots of total
RNA (5 g) were subjected to Northern blot analysis with the indi-
cated 32P-labeled probes. Unnamed S. pombe ORFs were as-
signed the gene name of the closest S. cerevisiae sequence ho-
molog.panel, lane 4). Under low oxygen conditions, transcrip-
Table 1. Sre1-Dependent Gene Expression
S. pombe ORF S. pombe Name S. cerevisiae Homolog Functiona Requires O2? Relative Expression
SPBC3B9.15c scp1+ SCAP ortholog No 16.2
SPAC222.11 HEM13 Coproporphyrinogen (III) oxidase Yes 5.9
SPAC30C2.02 mmd1+ YJR070C Mitochondrial morphology Unknown 2.7
SPAC630.08c ERG25 C-4 methyl sterol oxidase Yes 2.5
SPAC1687.16c ERG3 C-5 sterol desaturase Yes 2.2
SPBC19C2.09 sre1+ SREBP ortholog No 1.8
SPAC19G12.08 SCS7 Fatty acid hydroxylase Yes 1.8
SPAC222.13c PFK26 6-phosphofructo-2-kinase No 1.8
SPBC887.15c SUR2 Sphingosine hydroxylase Yes 1.8
SPAC17A2.05 OSM1 Fumarate reductase No 1.8
a Gene function data obtained from Incyte Proteome Bioknowledge Library.cells (Figure 3, lane 2), and this increase required acti-
vation of Sre1 (Figure 3, lanes 3 and 4). Actin (act1+)
served as a loading control. These data suggest that
Sre1 functions as a transcription factor and stimulates
gene expression in response to sterol depletion.
Sre1 Is Required for Anaerobic Growth
Gene deletion analysis revealed that yeast lacking
sre1+ or scp1+ exhibit wild-type growth at a range of
temperatures and on different media (our unpublished
data). This result was not unexpected, since only low
levels of Sre1-N are present under normal growth con-
ditions (Figure 2B, lane 5). However, the microarray ex-
periment suggested that Sre1 stimulated transcription
of genes required in low oxygen. Five genes code for
enzymes that use oxygen for their reaction mechanism,
and two genes, homologs of S. cerevisiae PFK26 and
OSM1, are required for the shift from respiratory to fer-
mentative growth. To examine the role of Sre1 in low
oxygen growth, yeast strains were grown on rich me-
dium in aerobic and anaerobic conditions (Figure 4A).
sre1D and scp1D cells failed to grow in the absence of
oxygen (Figure 4A, second panel), whereas sre2D and
ins1D cells grew like wild-type. Growth of a sre1D strain
was completely rescued by a plasmid expressing the
active, nuclear form of Sre1 (amino acids 1–440) from a
constitutive promoter (Figure 4A, Sre1-N, lower panel).
In addition, Sre1-N completely rescued growth of
scp1D, suggesting that, as in mammals, the essential
function of Scp1 is to activate Sre1 cleavage. Trans-
formation of an empty vector had no effect on growth.
These results indicate that sre1+ and scp1+ are essen-
tial for anaerobic growth.
The inability of sre1D cells to grow anaerobically sug-
gests that Sre1 may be activated under low oxygen
conditions. Consistent with this hypothesis, sterol syn-
thesis requires oxygen at multiple steps (Rosenfeld and
Beauvoit, 2003), and Sre1 is cleaved in sterol-depleted
cells (Figure 2). To test this prediction, wild-type and
mutant yeast strains were grown in the presence or ab-
sence of oxygen for 2 hr. Protein and total RNA were
isolated and subjected to immunoblot and Northern
analysis. Sre1 cleavage was highly induced in the ab-
sence of oxygen (Figure 4B, upper panel, lane 2). As
seen with compactin treatment, Sre1 cleavage was
Scp1 dependent, and the Sre1 precursor was de-
creased in the absence of Scp1 (Figure 4B, upper
Cell
836Figure 4. sre1+ and scp1+ Are Required for Anaerobic Growth and Gene Expression
(A) Wild-type and mutant yeast (5 × 103 cells) containing either no plasmid, empty vector, or a plasmid expressing Sre1-N (amino acids 1–
440) from the constitutive cauliflower mosaic virus promoter were spotted on rich medium and incubated at 30°C in aerobic (top panel) or
anaerobic (bottom panels) conditions for 3 or 4 days, respectively.
(B) Wild-type and mutant yeast strains were grown for 2 hr in aerobic (lane 1) or anaerobic (lanes 2–4) conditions. (Top panel) Cell extracts
were subjected to immunoblot analysis using anti-Sre1 IgG. (Bottom panel) Total RNA (5 g) was subjected to Northern blot analysis with the
indicated 32P-labeled probes.
(C) Wild-type yeast were shifted to anaerobic conditions at t = 0. At indicated time points, cell extracts and total RNA samples were prepared
and analyzed as described in (B).
(D) Wild-type yeast were cultured in the presence of 200 M compactin for the indicated times. Cell extracts and total RNA samples were
prepared and analyzed as described in (B). Exposure times are equivalent between (C) and (D) to permit a direct comparison.tion of hem13+, sre1+, erg3+, and erg25+ was highly t
iupregulated in a Sre1- and Scp1-dependent manner
(Figure 4B, lower panel), suggesting that Sre1 regulates c
the same genes under low oxygen and low sterol condi-
tions. Transcription of hmg1+ did not require Sre1 and a
served as a loading control. These data demonstratehat, in response to low oxygen, Sre1 cleavage is highly
nduced, leading to increased transcription of genes
oding for oxygen-dependent enzymes.
To examine the kinetics of Sre1 activation under an-
erobic conditions, wild-type cultures were grown in
the absence of oxygen for increasing time, and sam-
SREBP-SCAP Function as an Oxygen Sensor in Yeast
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analysis. Figure 4C shows that Sre1 activation occurred
rapidly, starting at 30 min and increasing to 8 hr (Figure
4C, upper panel). The time course for induction of
hem13+ and sre1+ mRNA mirrored that for Sre1 activa-
tion (Figure 4C, lower panel). hcs1+ mRNA served as a
loading control. Interestingly, Sre1 precursor levels in-
creased over time, likely due to increasing levels of
sre1+ mRNA. Given that the S. pombe cell cycle in
these conditions is approximately 2.5 hr, these data de-
monstrate that Sre1 is activated in a physiological time
course upon shifting to low oxygen.
To compare directly the response to low oxygen and
compactin, we performed a similar experiment using
wild-type cells treated with compactin. Sre1 activation
occurred at 2 hr and increased to 8 hr (Figure 4D);
however, the magnitude of the response was reduced
dramatically when compared to anaerobic induction.
Again, levels of hem13+ and sre1+ mRNA paralleled ac-
tivation of Sre1. Unlike low oxygen, Sre1 precursor
levels decreased steadily over time and then increased
at 8 hr, possibly due to the delayed increase in sre1+
mRNA. These data indicate that the cellular response
to the physiological signal of low oxygen is more rapid
and robust than pharmacological inhibition of sterol
synthesis by compactin.
Sre1 Mediates Adaptation to Hypoxia
Collectively, our data are consistent with a role for Sre1
in adaptation to hypoxia. Figure 5A outlines a model for
Sre1 function that is based on the following observa-
tions: first, Sre1 is activated in response to sterol deple-
tion or low oxygen; second, sterol synthesis requires
oxygen (Rosenfeld and Beauvoit, 2003); third, Sre1
stimulates transcription of genes coding for oxygen-
dependent enzymes and genes required for a shift to
fermentative growth; and fourth, sterols inhibit SREBP
cleavage in mammalian cells (Wang et al., 1994). Ac-
cording to this model, a decrease in oxygen concentra-
tion reduces ergosterol synthesis (step 1); reduced ste-
rol levels are then sensed by Sre1-Scp1, leading to Sre1
cleavage activation and transcription of oxygen-depen-
dent enzymes (step 2); higher enzyme concentration in-
creases utilization of available oxygen and synthesis of
oxygen-dependent products required for continued cell
growth (step 3); finally, the adaptive increase in sterol
synthesis feeds back to reduce Sre1 activation (step 4).
We presented evidence for step 2 in Figures 2–4. Here,
we examined whether steps 1, 3, and 4 also have an
experimental basis.
To test whether shifting to low oxygen decreased ste-
rol synthesis (step 1), we assayed ergosterol synthesis
during the first hour of hypoxic growth. During this
period, which we refer to as unadapted hypoxia, Sre1
was not fully active (see Figure 6A, lanes 1 and 2 and 7
and 8). Wild-type yeast were labeled for 1 hr with 14C-
acetate in the presence of oxygen (20.9%) or immedi-
ately after shifting cells to low oxygen. After 1 hr, sterols
were extracted and analyzed by thin layer chromatog-
raphy. Ergosterol synthesis decreased 5-fold upon
shifting cells to 0.2% oxygen and 30-fold upon shifting
to anaerobic conditions (Figure 5B, lanes 1, 2, and 6).
This decrease in synthesis was not due to decreased
14C-acetate uptake, since overall acetate incorporationFigure 5. Model for Sre1-Regulated Adaptation to Hypoxia
(A) Sre1 and Scp1 sense sterols as an indirect measure of oxygen
concentration. Step 1, reduced oxygen concentration lowers er-
gosterol synthesis. Step 2, sterol depletion induces cleavage and
activation of Sre1, leading to increased transcription of oxygen-
utilizing enzymes. Step 3, higher concentration of enzyme scav-
enges available oxygen by mass action, allowing synthesis of oxy-
gen-dependent products required for continued cell growth. Step
4, increased sterol synthesis downregulates Sre1 activation. E and
S denote enzyme and substrate, respectively.
(B) Wild-type and sre1D yeast were pulse labeled with 14C-acetate
at 30°C for 1 hr either under aerobic conditions (lane 1), immedi-
ately after shifting to low oxygen (unadapted; lanes 2, 3, and 6), or
after 4 hr in low oxygen (adapted; lanes 4, 5, and 7). Low oxygen
was either 0.2% oxygen (lanes 2–5) or anaerobic (lanes 6 and 7).
Sterols were extracted, analyzed by thin layer chromatography
(TLC), and quantified using a phosphorimager as described in Ex-
perimental Procedures. Data are the mean of six replicates from
two independent experiments. Error bars equal one standard devi-
ation. 1 OD unit = 1 × 107 cells.increased in 0.2% oxygen and was unchanged anaero-
bically (see Figure S1 in the Supplemental Data avail-
able with this article online). This result confirms step 1
of the model and demonstrates that ergosterol synthe-
sis decreases upon shift to low oxygen.
Step 3 of the model hypothesizes that, upon Sre1
activation, cells transition from an initial unadapted
hypoxic state to a Sre1-dependent adapted state. In
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Figure 6. Feedback Inhibition of Sre1 i
d(A) Wild-type yeast were cultured for the indicated times either in
0.2% oxygen or in anaerobic conditions. To minimize fluctuations w
in oxygen concentration caused by repeated entry to the worksta- 1
tion at 0.2% oxygen, each time point was a separate experiment c
performed consecutively over 3 days. The anaerobic experiment
bwas also performed using this method. Cells extracts (10 g) were
rsubjected to phosphatase treatment and immunoblot analysis with
vanti-Sre1 IgG.
(B) Wild-type S. pombe and S. cerevisiae were incubated with 0.01 T
Ci/ml 14C-cholesterol for 6 hr in the presence or absence of oxy- r
gen as indicated. Cholesterol uptake was measured as described S
in Experimental Procedures. Mean value from triplicate samples is
cshown above each column. Error bars equal one standard devi-
sation.
t
u
sthis adapted state, Sre1 target enzyme levels are ele-
evated, allowing cells to scavenge oxygen and synthe-
wsize oxygen-dependent products despite the hypoxic
fenvironment. Cells lacking Sre1 cannot adapt, and thus
isynthesis of oxygen-dependent products will remain at
lunadapted levels. To test this prediction, ergosterol
gsynthesis was assayed as above in wild-type and sre1D
ocells either immediately after shifting cells to low oxy-
gen (unadapted) or after 4 hr of hypoxic precondition-
ing (adapted). In the unadapted state, ergosterol syn- D
thesis was similar between wild-type cells and sre1D
cells (Figure 5B, lanes 2 and 3), indicating that Sre1 is I
snot required for sterol synthesis under these condi-
tions. In the adapted state, ergosterol synthesis in wild- O
mtype cells increased 5-fold, equaling that seen under
aerobic conditions (Figure 5B, lanes 1 and 4). Impor- s
ptantly, in sre1D cells, ergosterol synthesis was un-hanged, indicating that the adaptive response required
re1 (Figure 5B, lanes 3–5). Acetate incorporation was
imilar among these samples (Figure S1). These data
emonstrate that Sre1 is required for an adaptive
ncrease in ergosterol synthesis.
To test whether this adaptive increase in ergosterol
ynthesis leads to reduced Sre1 activation (Figure 5A,
tep 4), wild-type cells were cultured for increasing time
ither in 0.2% oxygen or anaerobic conditions. Sam-
les were phosphatase treated prior to immunoblot-
ing. The kinetics of Sre1 activation were similar be-
ween 0.2% oxygen and anaerobic conditions (Figure
A). However, in 0.2% oxygen, Sre1 activation was tran-
ient, increasing by 4 hr and then decreasing by 8 hr
Figure 6A, lanes 1–6). The duration of transient Sre1
ctivation at 0.2% oxygen varied between experiments,
ikely due to instability of the hypoxic workstation
±0.1%) and resultant variations in sterol synthesis. As
hown previously, under anaerobic conditions, Sre1 acti-
ation steadily increased to 8 hr (Figure 6A, lanes 7–12).
his failure to reduce Sre1 activation anaerobically
orrelated with low levels of ergosterol synthesis in the
dapted state (Figure 5B, lane 7). These data are con-
istent with step 4 of the model, in which feedback inhi-
ition limits Sre1 activation under conditions of in-
reased ergosterol synthesis.
Step 4 of the model also predicts that addition of
terols to cells should block cleavage of Sre1. However,
ddition of ergosterol, cholesterol, or 25-hydroxycho-
esterol, a potent inhibitor of mammalian SREBP cleav-
ge (Wang et al., 1994), had no effect on Sre1 cleavage
nduced by compactin or low oxygen (our unpublished
ata). To test if the failure to suppress Sre1 cleavage
as due to a defect in sterol import, we measured
4C-cholesterol uptake under aerobic and anaerobic
onditions. S. pombe failed to take up sterols under
oth conditions, whereas S. cerevisiae transported ste-
ols specifically under anaerobic conditions to pre-
iously published levels (Figure 6B) (Wilcox et al., 2002).
his phenomenon in S. cerevisiae is called aerobic ste-
ol exclusion (Lorenz and Parks, 1991). Thus, unlike
. cerevisiae, S. pombe does not import exogenous
holesterol, providing an explanation for the failure of
terols to inhibit Sre1 cleavage. This finding is consis-
ent with our model. If S. pombe were to import sterols
nder hypoxic conditions, activation of Sre1 would be
uppressed, and transcription of oxygen-dependent
nzymes would not increase. In this situation, cells
ould have a sufficient supply of sterol, but products
rom other oxygen-dependent reactions would be limit-
ng. Collectively, these results support the model out-
ined in Figure 5A in which Sre1 and Scp1 monitor oxy-
en-dependent sterol synthesis as an indirect measure
f oxygen supply and control adaptation to hypoxia.
iscussion
n the current study, we describe a eukaryotic oxygen-
ensing mechanism that requires the SREBP pathway.
ur data in fission yeast suggest that Sre1 and Scp1
onitor oxygen-dependent sterol synthesis as a mea-
ure of oxygen availability and control a transcriptional
rogram required for adaptation to hypoxia. In this
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839model (Figure 5A), low oxygen decreases sterol synthe-
sis, which in turn activates Sre1 and stimulates tran-
scription of genes required for hypoxic growth. The
resultant increase in oxygen-dependent enzymes main-
tains flux through reactions that may be rate limiting at
low oxygen concentrations. Similar models have been
proposed to explain upregulation of hypoxic genes in
S. cerevisiae (Kwast et al., 1998). This model for Sre1-
mediated adaptation to hypoxia is supported by the fol-
lowing evidence: (1) sre1+ and scp1+ are essential for
anaerobic growth (Figure 4A), (2) Sre1 is cleaved in ste-
rol-depleted cells (Figure 2), (3) low oxygen reduces
sterol synthesis (Figure 5B), (4) Sre1 is activated in low
oxygen (Figure 4C), (5) Sre1 activates genes required
for adaptation to hypoxia (Figure 4B), and (6) Sre1 acti-
vation is required to restore aerobic levels of sterol syn-
thesis under low oxygen conditions (Figure 5B). In this
study, we measured the effects of Sre1 activation on
sterol synthesis, but we speculate that other Sre1-
dependent pathways such as heme and sphingolipid
synthesis will respond similarly.
Cholesterol exerts feedback control on activation of
SREBP in mammalian cells (Rawson, 2003), and our
data are consistent with a similar role for sterols in the
regulation of Sre1 in S. pombe. Activation of Sre1 was
transient under conditions in which cells adapted to
low oxygen (0.2%) and increased ergosterol synthesis
(Figures 5B and 6A). However, under anaerobic condi-
tions in which ergosterol synthesis was severely im-
paired, Sre1 was not downregulated. The kinetics of
Sre1 activation in both conditions was rapid, suggest-
ing that low oxygen is a physiological signal for Sre1.
Interestingly, pharmacological inhibition of sterol syn-
thesis by compactin showed a delay in Sre1 activation
compared to low oxygen (Figure 4). These two treat-
ments affect ergosterol synthesis at different points.
Compactin inhibits an early step in ergosterol synthe-
sis, whereas low oxygen affects five independent reac-
tions late in the ergosterol pathway. Thus, compactin-
treated cells may continue to synthesize ergosterol
from preexisting intermediates, while hypoxic cells may
experience an immediate decrease in sterol synthesis
leading to more rapid Sre1 activation. Alternatively, ad-
ditional oxygen-dependent mechanisms may contrib-
ute to increases in Sre1 levels. In mammalian cells, hyp-
oxia blocks degradation of the hypoxic transcription
factor HIF1-α, and a similar mechanism may act on
Sre1 (Semenza, 2001).
Several lines of evidence indicate that Sre1 and Scp1
are functional orthologs of the corresponding mamma-
lian genes. First, protein topology and key functional
residues of SREBP and SCAP are conserved (Figure 1).
Second, endogenous Sre1 and Scp1 form a tight com-
plex in cells (Figure 1D), and Sre1 precursor levels are
reduced in the absence of Scp1 as observed in mam-
malian cells. Third, Sre1 is proteolytically cleaved in re-
sponse to sterol depletion through a Scp1-dependent
mechanism (Figure 2). By analogy to the mammalian
and D. melanogaster systems, Sre1 cleavage likely oc-
curs following transport to the Golgi (Rawson, 2003).
While Sre1 and Sre2 possess sequences in the pre-
dicted luminal loop that resemble the Site-1 protease
consensus cleavage site (RXXL/K) (Espenshade et al.,
1999), both proteins lack a sequence required forSite-2 protease cleavage (NP) in the first transmem-
brane segment of SREBP (Ye et al., 2000; Seegmiller et
al., 2002). A clear understanding of how Sre1 is re-
leased from the membrane awaits the identification of
the protease(s).
The ER resident protein Insig plays an important role
in sterol regulation of SREBP cleavage. In sterol-replete
mammalian cells, SCAP forms a complex with Insig,
blocking ER exit and cleavage of SREBP (Yang et al.,
2002). Interestingly unlike D. melanogaster (Rawson,
2003), S. pombe contains a homolog of Insig, ins1+, and
residues required for SCAP binding to Insig are con-
served in Scp1. Deletion of ins1+ had no effect on Sre1
activation, suggesting that a redundant protein or
mechanism exists to regulate ER exit of Sre1/Scp1 (Fig-
ure 2C). While the function of Ins1 is unclear, the pres-
ence of each component of the SREBP pathway in fis-
sion yeast, sre1+, scp1+, and ins1+, makes S. pombe an
ideal genetic model for future studies of sterol homeo-
stasis.
Microarray expression analysis of sterol-depleted yeast
reveals that Sre1 and SREBP regulate overlapping but
distinct sets of target genes (Table 1). In mammals,
SREBP regulates every enzyme required for sterol bio-
synthesis (Horton et al., 2003), while, in S. pombe, Sre1
appears to activate only genes in the late sterol path-
way. Furthermore, SREBP but not Sre1 regulates fatty
acid synthase, and Sre1 uniquely activates genes in
heme and sphingolipid synthesis (Table 1). Importantly,
Sre1 also activates transcription of pfk26+ and osm1+,
two genes involved in the transition from respiration to
fermentation that occurs in limiting oxygen conditions.
Collectively, these results suggest that Sre1 may play a
broad role in adaptation to hypoxia.
The discovery of SREBP in fission yeast but not bud-
ding yeast suggests that S. cerevisiae has non-SREBP
mechanisms for regulating sterol homeostasis and
adaptation to hypoxia. Indeed, the S. cerevisiae tran-
scription factor Upc2p stimulates expression of ergos-
terol biosynthetic and sterol uptake genes in sterol-
depleted cells (Wilcox et al., 2002; Vik and Rine, 2001).
However, Upc2p is a Zn[2]-Cys[6] binuclear cluster
transcription factor with no sequence homology to
SREBP (Vik and Rine, 2001). In S. cerevisiae, a heme-
dependent mechanism regulates expression of aerobic
and anaerobic genes through the activator Hap1p and
repressor Rox1p (Kwast et al., 2002). Interestingly, the
anaerobic expression of the Sre1-dependent genes
erg3+, erg25+, sur2+, scs7+, and hem13+ is controlled
by ROX1 in S. cerevisiae, suggesting that S. pombe and
S. cerevisiae may regulate similar genes hypoxically al-
beit through different mechanisms. While Sre1 is the
first mechanism of hypoxic regulation described in fis-
sion yeast, additional mechanisms may exist, such as
a heme-sensing pathway similar to the HAP1/ROX1
pathway in S. cerevisiae.
Importantly, fungal database searches revealed that
the Sre1/Scp1 pathway is not unique to S. pombe. Ho-
mologs of sre1+ and/or scp1+ were identified in several
ascomycetes, including Aspergillus and Neurospora,
and the basidomycetes Cryptococcus and Ustilago. No
identifiable homolog was found in Candida, a yeast
closely related to S. cerevisiae, suggesting that these
genes were lost from a common ancestor. Insomuch as
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840Psre1+ is required for hypoxic growth in S. pombe, the
YSREBP pathway represents a therapeutic target for
Ypathogenic fungi that propagate in hypoxic environ-
(
ments. T
In this study, we present data indicating that the b
lSREBP pathway functions as an oxygen sensor and is
1required for adaptation to hypoxia in fission yeast.
[Based on these findings, we propose that SREBP and
sSCAP may play an unrecognized role in oxygen sensing
a
in mammals. Unlike S. pombe, mammalian cells receive w
cholesterol from two sources: de novo synthesis and p
Treceptor-mediated endocytosis of low-density lipopro-
vtein (LDL). Consequently, in low-oxygen conditions,
5LDL cholesterol should suppress SREBP activation and
ablock induction of hypoxic genes. Therefore, we specu-
a
late that the SREBP hypoxic response may function in
nonhepatic tissues that have low levels of LDL receptor C
or during development prior to tissue vascularization Y
when supplies of oxygen and LDL are low. By focusing (
7on this simple genetic model, we hope to advance our
iunderstanding of sterol- and oxygen-sensing mecha-
snisms in mammals.

cExperimental Procedures
t
lMaterials and standard methods (cDNA cloning, plasmids, anti-
wbody preparation, immunoblot analysis, and Northern blot analysis)
tare described in Supplemental Experimental Procedures.
l
lStrains and Cell Culture
Wild-type haploid S. pombe were obtained from American Type
SCulture Collection, KGY425 (h−, his3-D1, leu1-32, ura4-D18, ade6-
DM210) (Burke and Gould, 1994). For all experiments, yeast were
fgrown to log phase at 30°C in Edinburgh minimal medium or YES
lmedium (0.5% [w/v] yeast extract plus 3% [w/v] glucose and sup-
tplements, 225 g/ml each of uracil, adenine, leucine, histidine, and
lysine) (Moreno et al., 1991). Standard genetic manipulations and
2molecular biology techniques were performed as described (Sam-
Rbrook and Russell, 2001; Alfa et al., 1993). S. cerevisiae strain
aFY833 (MATa, ura3-52, lys2-D202, trp1-D63, his3-D200, leu2-D1)
((Winston et al., 1995) used for cholesterol uptake assays was a gift
mfrom Rob Jensen (Johns Hopkins University) and was cultured at
g30°C in YEPD (2% peptone, 1% yeast extract, 2% glucose).
w
SGene Deletions and Epitope Tagging
4S. pombe strains sre1D, scp1D, sre2D, and ins1D, lacking the entire
wopen reading frame, and scp1-Myc were generated from wild-type
haploid yeast (KGY425) by homologous recombination using
established techniques (Bahler et al., 1998). Oligonucleotide se- E
Tquences used to generate the PCR fragments are listed in Supple-
mental Data (Table S1). b
i
sLow Oxygen Culture Conditions
For plate assays, yeast grown in YES (5 × 103 cells) were spotted c
0onto YES agar. Anaerobic growth conditions were maintained using
a BBL GasPak Jar and an anaerobic system envelope (Becton s
oDickinson). For Sre1 hypoxic cleavage assays, cells were grown in
YES and collected by centrifugation, and oxygenated medium was c
lremoved by aspiration. Cell pellets were resuspended in 5 ml of
deoxygenated YES inside an Invivo2 400 hypoxic workstation (Bio- a
ptrace, Inc.). Anaerobic conditions were maintained in the worksta-
tion using 10% hydrogen gas with balanced nitrogen in the pres- o
wence of palladium catalyst. Deoxygenated medium was prepared
by preincubation for >24 hr in the workstation. After resuspension, s
scultures were agitated at 30°C for indicated time, and 2 × 107 cells
of log phase cultures were harvested for protein extraction and o
uimmunoblotting. For time course experiments, individual cultures
were inoculated such that cell density was 1 × 107 cells/ml at har- c
evest. Hypoxic conditions (0.2% ± 0.1% oxygen) were maintained by
controlled mixing of air and nitrogen in an Invivo 400 workstation. u2roteolytic Processing of Sre1 and Phosphatase Treatment
east were grown in YES and treated as indicated in figure legends.
east (2 × 107 cells) were lysed by addition of 27 mM NaOH, 1%
v/v) 2-mercaptoethanol for 10 min on ice (Kornitzer et al., 1994).
otal protein was precipitated with 6.4% trichloroacetic acid followed
y an acetone wash. Proteins were solubilized with 100 l of SDS
ysis buffer (10 mM Tris-HCl [pH 6.8], 100 mM NaCl, 1% [w/v] SDS,
mM EDTA, 1 mM EGTA) plus protease inhibitors (25 g/ml ALLN
Calbiochem], 10 g/ml leupeptin, 2 g/ml aprotinin, 5 g/ml pep-
tatin A, 0.5 M PMSF, 1 mM DTT) and subjected to SDS-PAGE
nd immunoblot analysis. Unless noted, 40 g of total cell extract
as resolved for immunoblot analysis. For phosphatase treatment,
rotein aliquots (30 g) were mixed with an equal volume of 50 mM
ris-HCl (pH 8.0), 1% (w/v) SDS, 0.1% (v/v) 2-mercaptoethanol in a
olume of 15 l and boiled for 5 min. Following addition of 50 l of
0 mM Tris-HCl (pH 8.0), samples were divided into three aliquots
nd treated with alkaline phosphatase (0.05 U/l) and 25 mM EGTA
s indicated for 1 hr at 37°C.
oimmunoprecipitation
east (3 × 107 cells) grown in YES were lysed using glass beads
0.5 mm, Sigma) in 50 l NP-40 lysis buffer (50 mM HEPES [pH
.4], 100 mM NaCl, 1.5 mM MgCl2, 1% [v/v] NP-40) plus protease
nhibitors. Soluble proteins were immunoprecipitated in 1 ml of ly-
is buffer using 5 g of anti-Myc 9E10 monoclonal antibody and 20
l protein G-Sepharose (Amersham). After 2 hr at 4°C, beads were
ollected by centrifugation. The resulting supernatant was precipi-
ated with five volumes of cold acetone for 20 min at −20°C, fol-
owed by centrifugation at 4000 × g for 15 min. Precipitated protein
as resuspended in 100 l of SDS lysis buffer plus protease inhibi-
ors. Bound protein was washed three times with 1 ml of NP-40
ysis buffer plus protease inhibitors before resuspension in SDS
ysis buffer and immunoblot analysis.
. pombe DNA Microarray Analysis
ata shown in Table 1 represent the average relative expression
rom two normalized dye reversal hybridizations using mRNA iso-
ated from a single experiment. Total RNA was isolated from wild-
ype and scp1D yeast (2 × 109 cells) grown in YES containing 50
M compactin for 9 hr at 30°C. Poly(A+) mRNA was purified from
mg of total RNA using the Message Maker Kit (Life Technologies).
everse transcription and fluorescent aminoallyl dye coupling re-
ctions were performed according to manufacturer’s instructions
Eurogentec). Labeled cDNA samples from the two strains were
ixed and hybridized to a S. pombe DNA microarray slide (Euro-
entec) containing 4976 ORFs spotted in duplicate. Slides were
ashed sequentially at RT for 5 min each with 2× SSC, 0.2% (w/v)
DS; 2× SSC; and 0.2× SSC. Slides were scanned using a GenePix
000B scanner, and data were analyzed using GeneSpring 6 soft-
are (Silicon Genetics).
rgosterol Synthesis Assay
o measure ergosterol synthesis, cells grown in YES were collected
y centrifugation and resuspended in either oxygenated or hypox-
cally conditioned YES containing 2 Ci/ml 14C-acetic acid sodium
alt (110 mCi/mmol), such that cell density at harvest was 1 × 107
ells/ml. Cultures were then shaken at 30°C for 1 hr in normoxia,
.2% oxygen, or anaerobically using an Invivo2 400 hypoxic work-
tation. To measure ergosterol synthesis during the adapted hyp-
xic response, cultures were grown in 0.2% oxygen or anaerobi-
ally for 4 hr prior to addition of label. After 1 hr of growth with the
abel, acetate uptake was halted by addition of 10 mM sodium
zide. Yeast (5 × 107 cells) were collected by centrifugation, and
ellets were resuspended in 9 ml of methanol followed by addition
f 4.5 ml of 60% (w/v) KOH. 3H-cholesterol (0.5 Ci, 40 Ci/mmol)
as added to each sample as an internal standard to normalize for
terol extraction. Samples were heated to 75°C for 2 hr to saponify
terol esters. After cooling, sterols were extracted twice with 4 ml
f petroleum ether. Pooled fractions were evaporated to dryness
nder nitrogen gas and resuspended in 200 l of hexane. Five mi-
roliters of each sample was used to analyze 3H-cholesterol recov-
ry by scintillation counting. Samples were then concentrated
sing nitrogen gas to a final volume of 25 l and applied to Silica
SREBP-SCAP Function as an Oxygen Sensor in Yeast
841Gel 60 F254 plates (EMD Chemicals, Inc.). TLC was performed as
previously described (Gardner et al., 2001). 14C-labeled lipids were
detected by autoradiography using a Personal FX Molecular Im-
aging System (Biorad). Relative intensities of lipids on all plates
were converted to 14C-dpm by direct comparison to a standard
curve of known 14C-cholesterol concentrations. Sterol species
were identified by direct comparison to known standards visualized
by iodine vapor.
Cholesterol Uptake Assay
To measure cholesterol uptake, S. cerevisiae and S. pombe cells
grown in YEPD or YES, respectively, were collected and resus-
pended in appropriate oxygenated or deoxygenated medium con-
taining 0.01 Ci/ml 14C-cholesterol (55 mCi/mmol) and 1% tyloxa-
pol:ethanol (1:1, v/v). Cultures were grown with shaking at 30°C for
6 hr aerobically or anaerobically in an Invivo2 hypoxic workstation
such that cell density at harvest was 2 × 107 cells/ml. After 6 hr,
1 × 108 cells were collected by vacuum filtration onto preweighed
0.45 m HV Durapore membrane filters (Millipore). Cells were
washed twice with 0.5% tergitol (v/v) and once with water, after
which filters were dried and weighed. Total cholesterol incorpora-
tion was measured by scintillation counting, and final uptake values
were expressed as 14C-cholesterol-dpm/mg cell weight.
Supplemental Data
Supplemental Data include one figure, one table, Supplemental Ex-
perimental Procedures, and Supplemental References and are
available with this article online at http://www.cell.com/cgi/
content/full/120/6/831/DC1/.
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